1.32
price down icon0.75%   -0.01
after-market Dopo l'orario di chiusura: 1.33 0.01 +0.76%
loading
Precedente Chiudi:
$1.33
Aprire:
$1.33
Volume 24 ore:
1.52M
Relative Volume:
0.53
Capitalizzazione di mercato:
$93.86M
Reddito:
$391.70K
Utile/perdita netta:
$-52.34M
Rapporto P/E:
-1.76
EPS:
-0.75
Flusso di cassa netto:
$-45.92M
1 W Prestazione:
-5.04%
1M Prestazione:
-20.96%
6M Prestazione:
+343.25%
1 anno Prestazione:
+1.54%
Intervallo 1D:
Value
$1.24
$1.34
Intervallo di 1 settimana:
Value
$1.24
$1.435
Portata 52W:
Value
$0.2425
$2.01

Ovid Therapeutics Inc Stock (OVID) Company Profile

Name
Nome
Ovid Therapeutics Inc
Name
Telefono
212-776-4381
Name
Indirizzo
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Name
Dipendente
23
Name
Cinguettio
@OvidRx
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
OVID's Discussions on Twitter

Confronta OVID con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OVID
Ovid Therapeutics Inc
1.32 94.58M 391.70K -52.34M -45.92M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
409.47 105.61B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
657.53 67.99B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
442.70 58.19B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
854.65 52.40B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.70 39.60B 447.02M -1.18B -906.14M -6.1812

Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-09 Iniziato Oppenheimer Outperform
2025-08-08 Ripresa B. Riley Securities Buy
2024-06-18 Downgrade Oppenheimer Outperform → Perform
2024-04-30 Iniziato B. Riley Securities Buy
2024-04-29 Iniziato H.C. Wainwright Buy
2024-04-05 Iniziato Wedbush Outperform
2023-12-21 Iniziato BTIG Research Buy
2023-10-13 Iniziato Oppenheimer Outperform
2021-04-20 Downgrade Cantor Fitzgerald Buy → Neutral
2021-03-03 Downgrade RBC Capital Mkts Outperform → Sector Perform
2020-12-02 Downgrade Citigroup Buy → Neutral
2020-12-02 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2019-09-04 Iniziato RBC Capital Mkts Outperform
2018-04-20 Iniziato Ladenburg Thalmann Buy
Mostra tutto

Ovid Therapeutics Inc Borsa (OVID) Ultime notizie

pulisher
06:16 AM

Historical volatility pattern of Ovid Therapeutics Inc. visualizedWeekly Trend Summary & Safe Capital Investment Plans - newser.com

06:16 AM
pulisher
Nov 07, 2025

Published on: 2025-11-07 10:12:51 - newser.com

Nov 07, 2025
pulisher
Nov 07, 2025

Ovid Therapeutics Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView

Nov 07, 2025
pulisher
Nov 07, 2025

Visual trend scoring systems applied to Ovid Therapeutics Inc.Bull Run & Expert-Curated Trade Recommendations - newser.com

Nov 07, 2025
pulisher
Nov 06, 2025

How Ovid Therapeutics Inc. (1OT) stock correlates with oil markets2025 Earnings Impact & Capital Protection Trading Alerts - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Long term hold vs stop loss in Ovid Therapeutics Inc.July 2025 Setups & Step-by-Step Trade Execution Guides - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Visual analytics tools that track Ovid Therapeutics Inc. performanceJuly 2025 Volume & Verified High Yield Trade Plans - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Is Ovid Therapeutics Inc. (1OT) stock protected from inflationMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Can trapped investors hope for a rebound in Ovid Therapeutics Inc.Market Performance Summary & Fast Moving Stock Watchlists - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Combining machine learning predictions for Ovid Therapeutics Inc.Earnings Beat & Reliable Price Breakout Signals - newser.com

Nov 06, 2025
pulisher
Nov 06, 2025

Regression analysis insights on Ovid Therapeutics Inc. performanceTrade Entry Summary & Daily Growth Stock Investment Tips - newser.com

Nov 06, 2025
pulisher
Nov 05, 2025

Published on: 2025-11-05 21:39:18 - newser.com

Nov 05, 2025
pulisher
Nov 05, 2025

Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - MSN

Nov 05, 2025
pulisher
Nov 05, 2025

Ovid Therapeutics (OVID) to Release Earnings on Tuesday - MarketBeat

Nov 05, 2025
pulisher
Nov 04, 2025

Will Ovid Therapeutics Inc. stock deliver consistent dividends2025 Market Sentiment & Target Return Focused Stock Picks - fcp.pa.gov.br

Nov 04, 2025
pulisher
Nov 04, 2025

Published on: 2025-11-04 05:50:05 - newser.com

Nov 04, 2025
pulisher
Nov 03, 2025

Using flow based indicators on Ovid Therapeutics Inc.Trade Entry Report & Verified Swing Trading Watchlist - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

What MACD trends signal for Ovid Therapeutics Inc. (1OT) stockTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

OVID (Ovid Therapeutics) Total Payout Yield % : 0.00 (As of Nov. 02, 2025) - GuruFocus

Nov 02, 2025
pulisher
Nov 02, 2025

{固定前缀} Is SAIH a good long term investmentSector Performance Drivers & Get Free Expert Trading Recommendations - earlytimes.in

Nov 02, 2025
pulisher
Nov 01, 2025

Ovid Therapeutics Inc. (OVID) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Nov 01, 2025
pulisher
Nov 01, 2025

Is Ovid Therapeutics Inc. stock a safe haven assetWeekly Gains Summary & Scalable Portfolio Growth Methods - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

How Ovid Therapeutics Inc. (1OT) stock moves in volatile trading sessionsM&A Rumor & Reliable Entry Point Alerts - fcp.pa.gov.br

Nov 01, 2025
pulisher
Oct 31, 2025

Ovid Therapeutics (OVID) Price Target Increased by 22.06% to 4.23 - MSN

Oct 31, 2025
pulisher
Oct 31, 2025

Ovid Therapeutics Inc.Common Stock (Nasdaq:OVID) Stock Quote | PRN_FinancialWrapper | PR Newswire - Markets Financial Content

Oct 31, 2025

Ovid Therapeutics Inc Azioni (OVID) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Ovid Therapeutics Inc Azioni (OVID) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Rona Jeffrey A
CBFO
Feb 26 '25
Sale
0.56
3,902
2,185
67,973
ALEXANDER MARGARET A.
President and COO
Jan 27 '25
Buy
0.73
6,810
4,971
34,935
$38.56
price down icon 5.44%
$28.66
price down icon 0.62%
$105.98
price up icon 0.70%
$103.14
price down icon 0.20%
biotechnology ONC
$319.97
price down icon 3.73%
$189.70
price up icon 2.17%
Capitalizzazione:     |  Volume (24 ore):